Home » Newsletters » BioWorld Asia

BioWorld Asia

May 23, 2001

View Archived Issues

Zentaris Plans IPO In Germany To Fund 14 Pipeline Projects

Gene With Role In Malaria May Have Autoimmune Implications

NicOx Raises US$49M Through Public, Private Share Offering

UK Biotech Officials Need Better, More Open Dialogue With Public

Other News To Note

Crucell Enters Diabetes Deal Around Work At UMC Utrecht

European Industry Argues For No Change In GMO Labeling

Hybrigenics, Lynx Discover New Obesity Drug Target, Extend Deal

Specific Skills Required To Negotiate Beneficial Deals

CAT Enters Deal For Antibodies Against Two Immunex Targets

Memorec Completes EUR12.8M Round For Microarray Programs

EMEA Developing Guidelines For Use Of Transgenic Plants

Mindsense Biosystems Secures $2M For Biomarkers Technology

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...